Condensed Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands		Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss		Retained Earnings	Treasury Stock		Noncontrolling Interests in Subsidiaries
Beginning balance (in shares) at Dec. 26, 2021			35,797
Beginning balance at Dec. 26, 2021		$ (172,458)	$ 490	$ 445,126	$ (9,971)	[1]	$ 183,157	$ (806,472)		$ 15,212
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[2]	36,629					35,927			702
Other comprehensive income (loss), net of tax		(1,063)			(1,063)	[1]
Dividends on common stock		(25,055)		95			(25,150)
Exercise of stock options (in shares)			39
Exercise of stock options		$ 1,909	$ 1	1,908
Acquisition of Company common stock (in shares)		(753)	(753)
Acquisition of Company common stock		$ (75,471)						(75,471)
Stock-based compensation expense		9,100		9,100
Issuance of restricted stock (in shares)			229
Issuance of restricted stock		0		(6,450)				6,450
Tax effect of restricted stock awards (in shares)			(70)
Tax effect of restricted stock awards		(7,527)		(7,527)
Distributions to noncontrolling interests		(150)								(150)
Other (in shares)			6
Other		288		3				288		(3)
Ending balance (in shares) at Jun. 26, 2022			35,248
Ending balance at Jun. 26, 2022		(233,798)	$ 491	442,255	(11,034)	[1]	193,934	(875,205)		15,761
Beginning balance (in shares) at Mar. 27, 2022			35,675
Beginning balance at Mar. 27, 2022		(208,444)	$ 491	436,225	(9,316)	[1]	181,124	(832,603)		15,635
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[2]	25,712					25,433			279
Other comprehensive income (loss), net of tax		(1,718)			(1,718)	[1]
Dividends on common stock		(12,575)		48			(12,623)
Exercise of stock options (in shares)			22
Exercise of stock options		$ 1,167		1,167
Acquisition of Company common stock (in shares)		(452)	(452)
Acquisition of Company common stock		$ (42,762)						(42,762)
Stock-based compensation expense		4,925		4,925
Issuance of restricted stock (in shares)			2
Issuance of restricted stock		0		(81)				81
Tax effect of restricted stock awards (in shares)			(1)
Tax effect of restricted stock awards		(65)		(65)
Distributions to noncontrolling interests		(150)								(150)
Other (in shares)			2
Other		112		36				79		(3)
Ending balance (in shares) at Jun. 26, 2022			35,248
Ending balance at Jun. 26, 2022		$ (233,798)	$ 491	442,255	(11,034)	[1]	193,934	(875,205)		15,761
Beginning balance (in shares) at Dec. 25, 2022		34,700	34,736
Beginning balance at Dec. 25, 2022		$ (270,664)	$ 491	449,829	(10,135)	[3]	195,856	(922,434)	[4]	15,729
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[5]	40,300					40,144			156
Other comprehensive income (loss), net of tax		2,846			2,846	[3]
Dividends on common stock		(28,485)		54			(28,539)
Exercise of stock options (in shares)			17
Exercise of stock options		$ 683	$ 1	682
Acquisition of Company common stock (in shares)		(2,523)	(2,523)
Acquisition of Company common stock		$ (212,444)						(212,444)	[4]
Stock-based compensation expense		8,498		8,498
Issuance of restricted stock (in shares)			227
Issuance of restricted stock		0		(6,542)				6,542	[4]
Tax effect of restricted stock awards (in shares)			(73)
Tax effect of restricted stock awards		(6,108)		(6,108)
Distributions to noncontrolling interests		(323)								(323)
Other (in shares)			10
Other		$ 218		(449)				667	[4]
Ending balance (in shares) at Jun. 25, 2023		32,400	32,394
Ending balance at Jun. 25, 2023		$ (465,479)	$ 492	445,964	(7,289)	[3]	207,461	(1,127,669)	[4]	15,562
Beginning balance (in shares) at Mar. 26, 2023			32,356
Beginning balance at Mar. 26, 2023		(475,325)	$ 492	443,686	(8,766)	[3]	203,569	(1,130,136)	[4]	15,830
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[5]	17,800					17,768			32
Other comprehensive income (loss), net of tax		1,477			1,477	[3]
Dividends on common stock		(13,822)		54			(13,876)
Exercise of stock options (in shares)			2
Exercise of stock options		$ 68		68
Acquisition of Company common stock (in shares)		0
Stock-based compensation expense		$ 4,601		4,601
Issuance of restricted stock (in shares)			30
Issuance of restricted stock		0		(1,933)				1,933	[4]
Tax effect of restricted stock awards (in shares)			(1)
Tax effect of restricted stock awards		(109)		(109)
Distributions to noncontrolling interests		(300)								(300)
Other (in shares)			7
Other		$ 131		(403)				534	[4]
Ending balance (in shares) at Jun. 25, 2023		32,400	32,394
Ending balance at Jun. 25, 2023		$ (465,479)	$ 492	$ 445,964	$ (7,289)	[3]	$ 207,461	$ (1,127,669)	[4]	$ 15,562

[1] At June 26, 2022, the accumulated other comprehensive loss of $11,034 was comprised of net unrealized foreign currency translation loss of $8,696 and net unrealized loss on the interest rate swap agreements of $2,338.

[2] Net income to the Company for the three and six months ended June 26, 2022 excludes $18 and $528, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.

[3] At June 25, 2023, the accumulated other comprehensive loss of $7,289 was comprised of net unrealized foreign currency translation loss of $7,274 and net unrealized loss on the interest rate swap agreements of $15.

[4] Acquisition of Company common stock for the six months ended June 25, 2023 includes $2,804 of transaction costs directly attributable to share repurchases, including a 1% excise tax incurred under the Inflation Reduction Act of 2022.

[5] Net income to the Company for the three and six months ended June 25, 2023 excludes $59 and $105, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.